Pharmaceuticals, Biotechnology and Life Sciences
Final overall survival (OS) analysis did not demonstrate a statistically significant advantage for MARGENZA over trastuzumabOS was greater with MARGENZA…
H.C. Wainwright 23rd Global Investor Conference: September 13th – 15th Benzinga Healthcare Small Cap Conference: September 29th – 30th NEW…
BURLINGAME, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that…
REDWOOD CITY, Calif., Sept. 07, 2021 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused…
SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered…
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 06, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives…
ERYTECH to Present at the H.C. Wainwright 23rd Annual Global Investment Conference Cambridge, MA (U.S.) and Lyon (France), September 6,…
Oslo, 6 September 2021 In accordance with the authorisation granted and the remuneration policy adopted by the…
VALNEVA Déclaration d’actions et de droits de vote – Août 2021 Dénomination sociale : VALNEVAAdresse du siège social : 6 rue Alain…
– One complete response, and a disease control rate of 64% with stable disease for ≥16 weeks in two patients,…